Dongcheng Pharmaceutical announced that Shanxiandike Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Andike, has received a “Radiopharmaceutical Production License” issued by the Shanxi Drug Administration, and the Shanxi Jinzhong Nuclear Drug Production Center has been approved for operation. The drug is a fluorine [F] deoxyglucose injection. The commissioning of the center will help Andeco develop markets, increase revenue, and improve the network layout of nuclear drugs across the country.

Dongcheng Pharmaceutical announced that Shanxiandike Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Andike, has received a “Radiopharmaceutical Production License” issued by the Shanxi Drug Administration, and the Shanxi Jinzhong Nuclear Drug Production Center has been approved for operation. The drug is a fluorine [F] deoxyglucose injection. The commissioning of the center will help Andeco develop markets, increase revenue, and improve the network layout of nuclear drugs across the country.